Robert B. Doherty, BA
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: Customer Service, American College of Physicians, 190 N. Independence Mall West, Philadelphia, PA 19106.
The Medicare Modernization Act (MMA) is the product of a political compromise to attract moderate Republicans and enough Democrats without losing Republican conservatives. The compromise offered more private health plans to beneficiaries while maintaining and improving traditional Medicare's benefits. This compromise did not settle the debate over the legislation, which is a major issue in the 2004 elections. Voters poorly understand the law because of its complexity. In this paper, I explain how the policy decisions made by the U.S. Congress have contributed to the law's complexity and controversy. I examine the new private health plan options that will be offered to beneficiaries, improvements made to traditional Medicare, and the impact of introducing income-based determinations into Medicare. I also discuss the impact of the drug benefit on beneficiaries in different income and assets categories and Congress's decision to prohibit the federal government from directly negotiating prices with drug manufacturers. I conclude by assessing the major claims made by critics and proponents. Both might be more circumspect in their assessments of the law's impact, since it is impossible to predict how a law of such complexity, with so many human variables, will work out in the end. The MMA is a worthwhile but imperfect effort to extend drug coverage to seniors who are most in need. It deserves neither condemnation nor indiscriminate praise but instead a commitment to help it succeed.
By offering beneficiaries a choice of enrolling in private plans or in traditional Medicare with new preventive benefits, Congress adds complexity to the decision-making process for beneficiaries.
By insisting that the benefit stay within a $400 billion expenditure limit over 10 years, Congress had to create a confusing cost-sharing structure to keep costs down.
By departing from Medicare's policy of providing the same benefits at the same cost to all beneficiaries, Congress introduced complex determinations for assets and income.
By prohibiting direct price negotiation between the federal government and drug companies and instead relying on private insurers to negotiate discounts, Congress assures that drug costs and formularies will vary from plan to plan and locality to locality.
Table. Drug Benefit Based on Beneficiaries' Incomes and Assets
It is clear … from the Medicare experience that in such a program everything depends on the human factor, on how patients, physicians, hospital administrators, insurers and others behave. The program is not a mechanical model but a system that has all the messiness that arises when human beings are called on to run complicated, interrelated institutions that depend on human behavior. We should not be discouraged about further extensions of health insurance, but neither should we expect a smooth-running, purring machine.
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Doherty RB. Assessing the New Medicare Prescription Drug Law. Ann Intern Med. 2004;141:391–395. doi: 10.7326/0003-4819-141-5-200409070-00100
Download citation file:
Published: Ann Intern Med. 2004;141(5):391-395.
Healthcare Delivery and Policy.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only